Updated on 3 August 2016
(Photo Courtesy: www.henmores.co.uk)
Piramal Pharma Solutions' plan focuses on expanding the Lexington site capabilities and capacity for commercial aseptic manufacturing.
This will be done by increasing vial filling capability and lyophilization capacity, as well as upgrades to the associated facilities and utilities.
Piramal's Lexington site has a strong pipeline of products which are expected to be commercialized in next 3 to 5 years.
Add to that the fast growing Sterile Market in the US, recent consolidations in the CMO space and shut down of many manufacturing sites in the US, has created a big demand for quality manufacturers in the Sterile segment.
The Sterile market in the US and Europe is growing at a healthy rate of 11% and the Contract Manufacturing in the Sterile Dosage Form is growing at 13% year on year.